Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer

Liao,Mei-Ying; Kuo,Mark Yen-Ping; Lu,Tung-Ying; Wang,Yi-Ping; Wu,Han-Chung

doi:10.3892/ijo.2015.2876

Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer

Authors:
- Mei-Ying Liao
- Mark Yen-Ping Kuo
- Tung-Ying Lu
- Yi-Ping Wang
- Han-Chung Wu
View Affiliations

Affiliations: Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan, R.O.C., Institute of Cellular and Organismic Biology, Academia Sinica, Taipei 115, Taiwan, R.O.C.
Published online on: February 5, 2015 https://doi.org/10.3892/ijo.2015.2876
Pages: 1788-1800

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

We have generated a novel monoclonal antibody (mAb), OCAb9-1, which specifically binds to various types of cancer cell lines, but not to normal cells. According to the results of immunoaffinity chromatography, LC-MS/MS analysis, co-immunoprecipitation, and RNA interference studies, the target protein of OCAb9-1 is the epithelial cell adhesion molecule (EpCAM). EpCAM is a type I transmembrane glycoprotein which is highly expressed in epithelial-transformed neoplasia and tumor-initiating cells (TICs). However, regulation of EpCAM gene expression in tumors and its role in tumorigenesis are not fully understood. In the present study, we show that EpCAM expression is elevated in several cancer cell lines and tumor tissues. Loss-of-function experiments were performed to demonstrate that EpCAM negatively regulates expression of p53 and p21, and promotes tumor cell growth, colony formation, migration and invasion. The median overall survival of tumor-bearing mice treated with OCAb9-1 was significantly higher than that of PBS-treated mice. Moreover, we report that the interplay between SUZ12 and JMJD3 results in dynamic regulation of lysine 27 trimethylation of histone 3 (H3K27me3). Taken together, our findings suggest that the anti-EpCAM mAb may be suitable for use in cancer diagnosis, prognosis, imaging and therapy. Furthermore, EpCAM overexpression in cancer cells is strongly associated with tumor progression, and may be regulated by epigenetic mechanisms.

View References

1	Peto J: Cancer epidemiology in the last century and the next decade. Nature. 411:390–395. 2001. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
3	van der Gun BT, Melchers LJ, Ruiters MH, et al: EpCAM in carcinogenesis: the good, the bad or the ugly. Carcinogenesis. 31:1913–1921. 2010. View Article : Google Scholar : PubMed/NCBI
4	Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
5	Litvinov SV, Velders MP, Bakker HA, et al: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol. 125:437–446. 1994. View Article : Google Scholar : PubMed/NCBI
6	Litvinov SV, Balzar M, Winter MJ, et al: Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol. 139:1337–1348. 1997. View Article : Google Scholar
7	Balzar M, Prins FA, Bakker HA, et al: The structural analysis of adhesions mediated by Ep-CAM. Exp Cell Res. 246:108–121. 1999. View Article : Google Scholar : PubMed/NCBI
8	de Boer CJ, van Krieken JH, Janssen-van Rhijn CM, et al: Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver. J Pathol. 188:201–206. 1999. View Article : Google Scholar : PubMed/NCBI
9	Litvinov SV, van Driel W, van Rhijn CM, et al: Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am J Pathol. 148:865–875. 1996.PubMed/NCBI
10	Maetzel D, Denzel S, Mack B, et al: Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol. 11:162–171. 2009. View Article : Google Scholar : PubMed/NCBI
11	Al-Hajj M, Wicha MS, Benito-Hernandez A, et al: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
12	Dalerba P, Dylla SJ, Park IK, et al: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
13	Schmelzer E, Wauthier E and Reid LM: The phenotypes of pluripotent human hepatic progenitors. Stem Cells. 24:1852–1858. 2006. View Article : Google Scholar : PubMed/NCBI
14	Dan YY, Riehle KJ, Lazaro C, et al: Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc Natl Acad Sci USA. 103:9912–9917. 2006. View Article : Google Scholar : PubMed/NCBI
15	Schmelzer E, Zhang L, Bruce A, et al: Human hepatic stem cells from fetal and postnatal donors. J Exp Med. 204:1973–1987. 2007. View Article : Google Scholar : PubMed/NCBI
16	Anderson R, Schaible K, Heasman J, et al: Expression of the homophilic adhesion molecule, Ep-CAM, in the mammalian germ line. J Reprod Fertil. 116:379–384. 1999. View Article : Google Scholar
17	Stingl J, Raouf A, Emerman JT, et al: Epithelial progenitors in the normal human mammary gland. J Mammary Gland Biol Neoplasia. 10:49–59. 2005. View Article : Google Scholar : PubMed/NCBI
18	Moldenhauer G, Salnikov AV, Luttgau S, et al: Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma. J Natl Cancer Inst. 104:622–634. 2012. View Article : Google Scholar : PubMed/NCBI
19	Simon M, Stefan N, Pluckthun A, et al: Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy. Expert Opin Drug Deliv. 10:451–468. 2013. View Article : Google Scholar : PubMed/NCBI
20	Punt CJ, Nagy A, Douillard JY, et al: Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study. Lancet. 360:671–677. 2002. View Article : Google Scholar : PubMed/NCBI
21	Schmidt M, Scheulen ME, Dittrich C, et al: An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer. Ann Oncol. 21:275–282. 2010. View Article : Google Scholar
22	Went P, Vasei M, Bubendorf L, et al: Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer. 94:128–135. 2006. View Article : Google Scholar : PubMed/NCBI
23	MacDonald GC, Rasamoelisolo M, Entwistle J, et al: A phase I clinical study of VB4-845: weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck. Drug Des Devel Ther. 2:105–114. 2009.PubMed/NCBI
24	Migliore L, Migheli F, Spisni R, et al: Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol. 2011:7923622011. View Article : Google Scholar : PubMed/NCBI
25	Coppede F: Epigenetic biomarkers of colorectal cancer: focus on DNA methylation. Cancer Lett. 342:238–247. 2014. View Article : Google Scholar
26	Tai KY, Shiah SG, Shieh YS, et al: DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression. Oncogene. 26:3989–3997. 2007. View Article : Google Scholar : PubMed/NCBI
27	Spizzo G, Gastl G, Obrist P, et al: Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue. Cancer Lett. 246:253–261. 2007. View Article : Google Scholar
28	Yu G, Zhang X, Wang H, et al: CpG island methylation status in the EpCAM promoter region and gene expression. Oncol Rep. 20:1061–1067. 2008.PubMed/NCBI
29	Shiah SG, Chang LC, Tai KY, et al: The involvement of promoter methylation and DNA methyltransferase-1 in the regulation of EpCAM expression in oral squamous cell carcinoma. Oral Oncol. 45:e1–8. 2009. View Article : Google Scholar
30	van der Gun BT, Wasserkort R, Monami A, et al: Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation. Int J Cancer. 123:484–489. 2008. View Article : Google Scholar : PubMed/NCBI
31	Heyn H and Esteller M: DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet. 13:679–692. 2012. View Article : Google Scholar : PubMed/NCBI
32	Lin CT, Chan WY, Chen W, et al: Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest. 68:716–727. 1993.PubMed/NCBI
33	Oefinger PE, Bronson DL and Dreesman GR: Induction of hepatitis B surface antigen in human hepatoma-derived cell lines. J Gen Virol. 53:105–113. 1981. View Article : Google Scholar : PubMed/NCBI
34	Lo A, Lin CT and Wu HC: Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery. Mol Cancer Ther. 7:579–589. 2008. View Article : Google Scholar : PubMed/NCBI
35	Lee TY, Wu HC, Tseng YL, et al: A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery. Cancer Res. 64:8002–8008. 2004. View Article : Google Scholar : PubMed/NCBI
36	Kohler G and Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:495–497. 1975. View Article : Google Scholar : PubMed/NCBI
37	Liu IJ, Chiu CY, Chen YC, et al: Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J Biol Chem. 286:9726–9736. 2011. View Article : Google Scholar : PubMed/NCBI
38	Tung KH, Lin CW, Kuo CC, et al: CHC promotes tumor growth and angiogenesis through regulation of HIF-1alpha and VEGF signaling. Cancer Lett. 331:58–67. 2013. View Article : Google Scholar
39	Spizzo G, Went P, Dirnhofer S, et al: High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res Treat. 86:207–213. 2004. View Article : Google Scholar : PubMed/NCBI
40	Lu TY, Kao CF, Lin CT, et al: DNA methylation and histone modification regulate silencing of OPG during tumor progression. J Cell Biochem. 108:315–325. 2009. View Article : Google Scholar : PubMed/NCBI
41	Huang HP, Chen PH, Yu CY, et al: Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming. J Biol Chem. 286:33520–33532. 2011. View Article : Google Scholar : PubMed/NCBI
42	Esteller M: Epigenetics in cancer. N Engl J Med. 358:1148–1159. 2008. View Article : Google Scholar : PubMed/NCBI
43	Bernstein BE, Kamal M, Lindblad-Toh K, et al: Genomic maps and comparative analysis of histone modifications in human and mouse. Cell. 120:169–181. 2005. View Article : Google Scholar : PubMed/NCBI
44	Barski A, Cuddapah S, Cui K, et al: High-resolution profiling of histone methylations in the human genome. Cell. 129:823–837. 2007. View Article : Google Scholar : PubMed/NCBI
45	Mutskov V and Felsenfeld G: Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J. 23:138–149. 2004. View Article : Google Scholar
46	Munz M, Baeuerle PA and Gires O: The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res. 69:5627–5629. 2009. View Article : Google Scholar : PubMed/NCBI
47	Gires O, Klein CA and Baeuerle PA: On the abundance of EpCAM on cancer stem cells. Nat Rev Cancer. 9:143author reply 143. 2009. View Article : Google Scholar : PubMed/NCBI
48	Saltz LB, Cox JV, Blanke C, et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med. 343:905–914. 2000. View Article : Google Scholar : PubMed/NCBI
49	Fields AL, Keller A, Schwartzberg L, et al: Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer. J Clin Oncol. 27:1941–1947. 2009. View Article : Google Scholar : PubMed/NCBI
50	de Bono JS, Tolcher AW, Forero A, et al: ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas. Clin Cancer Res. 10:7555–7565. 2004. View Article : Google Scholar : PubMed/NCBI
51	Goel S, Bauer RJ, Desai K, et al: Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineere monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors. Ann Oncol. 18:1704–1707. 2007. View Article : Google Scholar : PubMed/NCBI
52	Lin CW, Liao MY, Lin WW, et al: Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer. J Biol Chem. 287:39449–39459. 2012. View Article : Google Scholar : PubMed/NCBI
53	Schuettengruber B, Chourrout D, Vervoort M, et al: Genome regulation by polycomb and trithorax proteins. Cell. 128:735–745. 2007. View Article : Google Scholar : PubMed/NCBI
54	Schwartz YB and Pirrotta V: Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet. 8:9–22. 2007. View Article : Google Scholar
55	Cao R and Zhang Y: SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell. 15:57–67. 2004. View Article : Google Scholar : PubMed/NCBI
56	Pasini D, Bracken AP, Jensen MR, et al: Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J. 23:4061–4071. 2004. View Article : Google Scholar : PubMed/NCBI
57	Swigut T and Wysocka J: H3K27 demethylases, at long last. Cell. 131:29–32. 2007. View Article : Google Scholar : PubMed/NCBI
58	Agger K, Cloos PA, Christensen J, et al: UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature. 449:731–734. 2007. View Article : Google Scholar : PubMed/NCBI
59	Boyer LA, Plath K, Zeitlinger J, et al: Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 441:349–353. 2006. View Article : Google Scholar : PubMed/NCBI